1. Home
  2. VKTX vs USLM Comparison

VKTX vs USLM Comparison

Compare VKTX & USLM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VKTX
  • USLM
  • Stock Information
  • Founded
  • VKTX 2012
  • USLM 1948
  • Country
  • VKTX United States
  • USLM United States
  • Employees
  • VKTX N/A
  • USLM N/A
  • Industry
  • VKTX Biotechnology: Pharmaceutical Preparations
  • USLM Other Metals and Minerals
  • Sector
  • VKTX Health Care
  • USLM Industrials
  • Exchange
  • VKTX Nasdaq
  • USLM Nasdaq
  • Market Cap
  • VKTX 3.8B
  • USLM 3.6B
  • IPO Year
  • VKTX 2015
  • USLM N/A
  • Fundamental
  • Price
  • VKTX $35.22
  • USLM $127.71
  • Analyst Decision
  • VKTX Strong Buy
  • USLM
  • Analyst Count
  • VKTX 14
  • USLM 0
  • Target Price
  • VKTX $87.00
  • USLM N/A
  • AVG Volume (30 Days)
  • VKTX 4.8M
  • USLM 76.6K
  • Earning Date
  • VKTX 10-22-2025
  • USLM 10-29-2025
  • Dividend Yield
  • VKTX N/A
  • USLM 0.19%
  • EPS Growth
  • VKTX N/A
  • USLM 44.81
  • EPS
  • VKTX N/A
  • USLM 4.36
  • Revenue
  • VKTX N/A
  • USLM $352,260,000.00
  • Revenue This Year
  • VKTX N/A
  • USLM $22.64
  • Revenue Next Year
  • VKTX N/A
  • USLM $8.38
  • P/E Ratio
  • VKTX N/A
  • USLM $29.62
  • Revenue Growth
  • VKTX N/A
  • USLM 21.97
  • 52 Week Low
  • VKTX $18.92
  • USLM $80.47
  • 52 Week High
  • VKTX $79.10
  • USLM $159.53
  • Technical
  • Relative Strength Index (RSI)
  • VKTX 60.22
  • USLM 47.39
  • Support Level
  • VKTX $33.00
  • USLM $131.11
  • Resistance Level
  • VKTX $36.11
  • USLM $137.96
  • Average True Range (ATR)
  • VKTX 2.02
  • USLM 3.87
  • MACD
  • VKTX 0.09
  • USLM -0.47
  • Stochastic Oscillator
  • VKTX 73.40
  • USLM 45.27

About VKTX Viking Therapeutics Inc.

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

About USLM United States Lime & Minerals Inc.

United States Lime & Minerals Inc is engaged in the business of manufacturing lime and limestone products including PLS, quicklime, hydrated lime and lime slurry. It supplies its products predominantly to the construction (including highway, road, and building contractors), industrial (including paper and glass manufacturers), environmental (including municipal sanitation and water treatment facilities and flue gas treatment processes), metals (including steel producers), oil and gas services, roof shingle manufacturers and agriculture (including poultry and cattle feed producers) industries. The company operates through its Lime and Limestone Operations segment.

Share on Social Networks: